New biomarkers

Published on 15 November 2026 · Last updated on 15 November 2026 · Reading time about 12 minutes

Also in Heart and vascular condition

A walker in their fifties stands smiling on a dune path by the sea, feeling their own heart rhythm with two fingers on the wrist

In short

  • People who were both cardiometabolically unhealthy and pre-frail or frail had almost three times the risk of a heart that pumps too weakly and about one and a half times the risk of an irregular heart rhythm, compared with people who were healthy on both counts.⁠1
  • Together, a metabolism under strain and frailty brought more risk than their two separate risks added together.⁠1
  • A protein released by fat cells, FABP4, was the most consistent signal along that route, but the authors call that signal preliminary and still to be checked in other groups.⁠1
  • The heart and blood vessel scan gives you a first picture of where you stand today. It is insight, and the scan is not a diagnosis.

Why your heart rhythm depends on more than your heart

In this piece you will read how your metabolism and frailty together relate to your heart rhythm and to how strongly your heart pumps, and why a protein made by fat cells has come forward as an early signal along that route. That matters, because the combination weighed more heavily than each part on its own, and you can get a picture of both parts long before your heart gives you a reason to worry.

At work you take the stairs and notice that you stop on the landing more often than you used to. Your waistband is tighter than last year, your GP mentioned your blood pressure in passing at your last visit, and on some evenings on the sofa you feel your heart skip a beat. None of it feels like something to dwell on. Each piece seems small enough to leave be, and no one has ever told you whether the pieces add up.

You are not the only one

Where pieces like these can lead is not rare. In the Netherlands, the RIVM recorded on its public health website VZinfo about 8,000 deaths in 2023 from a heart that pumps less strongly than the body needs, a condition a doctor puts a name to.⁠2 The same source counted more than 32,200 hospital admissions in 2023 for that condition.⁠3

The study this piece is about shows how big it is from another angle. Of the 319,048 adults the study followed, 17,844 developed an irregular heart rhythm that a doctor gives a name to during the follow-up, and 5,410 the weaker pumping heart.⁠1 Those are not small numbers, and every person behind them started out without either condition.

Why heart rhythm and pumping strength go off course

Your heart has two jobs that this piece keeps apart. The first is rhythm: the beat that should come at an even pace. When the upper part of the heart beats irregularly, a doctor gives that heart rhythm disorder a name; in this text it is simply called the rhythm condition. The second is pumping strength: how much blood the heart pumps around with each beat. When the heart pumps less blood around than the body needs, a doctor gives that a name too; here it is the pumping condition. Rhythm is not the same as heart rate: your heart rate is how many beats you have, the rhythm is how regularly they come. You can read what counts as a normal heart rate on our page about a normal heart rate.

The two conditions are linked. In the new study, 2,403 people went on from the rhythm condition to both, and 791 went the other way, from the pumping condition to both.⁠1

Part of the reason the heart drifts off course lies in metabolism. Earlier research found that people with several conditions of the heart, blood vessels and metabolism at once had a higher chance of the rhythm condition, and that this chance rose with each extra condition.⁠4 In other words, the strain on the heart seems to build up rather than stay the same.

A second part is reserve. Frailty describes, in plain words, a body with less in the tank than it used to have: less strength, less stamina, slower to get back on your feet. Frailty is easy to see and easy to brush aside, because it creeps in slowly. You can read what long periods of sitting still do to that reserve in what moving too little does to your body.

This is where the knowledge stopped. The finding from that earlier research is only about conditions of the metabolism. Whether a metabolism under strain and frailty together weigh more heavily than each on its own, whether they also push the step from one heart condition to both, and what travels in the blood alongside that combination: those questions were still open.

A new study weighs metabolism and frailty together

Two friends in their fifties cycle side by side along a city canal, laughing

The study comes from Cui C, Liu B, Zhang G, Du Z and Cheng W. The authors work at the Department of Cardiology of The First Affiliated Hospital of Bengbu Medical University, at Bengbu Medical University and at Zhejiang Chinese Medical University in Hangzhou, China. The paper appeared on 10 October 2026 in The journal of nutrition, health & aging, as a journal article.⁠1

The team used data from 319,048 UK Biobank participants who had no rhythm condition and no pumping condition at the start. Each of them was placed in one of four groups based on two questions. Was their cardiometabolic health, the health of the heart, blood vessels and metabolism together, healthy or unhealthy? And were they not frail, or pre-frail or frail? The group that was healthy on both counts served as the benchmark. The team then followed who developed which condition, and who went on from one condition to both.⁠1

The main finding is simple. People who were both cardiometabolically unhealthy and pre-frail or frail had the highest risk of all four groups: almost three times the risk of the pumping condition, and about one and a half times the risk of the rhythm condition, compared with the group that was healthy on both counts.⁠1

Why this matters to you: the two pieces in this finding are not hidden. A body with a metabolism under strain and a body losing reserve are both things you can notice in an ordinary week, on the stairs or in the numbers at a check-up. What the study adds is that the pieces should not be judged one at a time. Together they pointed to the people at highest risk, and they did so in people who had neither heart condition at the start.

What the combination added up to

A couple in their fifties make a salad together with fresh vegetables and herbs in a bright kitchen

The combination did more than raise the chance of a first heart condition. The same group was also more likely to go on from the rhythm condition to both, about three quarters more likely than the reference group, and a little more likely, about a quarter more, to go on from the pumping condition to both.⁠1

The most telling finding is about the sum. If a metabolism under strain and frailty each simply brought their own share of the risk, the risk of both together would be the two shares added up. It was more than that. The authors found that the two together brought more risk than their separate risks added together.⁠1 A metabolism under strain and frailty occurring together pointed, in the authors’ words, to the people at greatest risk.

The summary does not report how frailty was measured in this study. That matters less than it sounds, because frailty can be assessed without any devices. A team at Juntendo University found that a short frailty score, the Clinical Frailty Scale, is a quick way to estimate risk in patients with the pumping condition, and researcher Taisuke Nakade described the score like this:⁠5

CFS offers a quick bedside assessment, done by eye, that needs no equipment or specialised training.

Taisuke Nakade, Researcher, Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine

One protein on the route

There is one idea this piece wants to explain well: what it means when a protein lies on the route between a risk and an outcome.

FABP4 is a protein made mainly in fat cells and in certain immune cells, and it plays a role in how the body responds to insulin.⁠6 Fat cells release it, and a review article from UMC Utrecht looked at what FABP4 means for the heart and blood vessels in an ageing population.⁠7 In the new study, FABP4 was one of the proteins measured in blood plasma.

In 28,206 of the participants, a broad range of proteins in the plasma was measured. Thirteen proteins gave a statistical signal for both heart conditions. FABP4 stood out. In the statistics, about half of the link between the combined group and the rhythm condition ran in step with FABP4, and about a third of the link with the pumping condition. FABP4 also gave signals for the first step towards the rhythm condition and for the step from that condition to both.⁠1

The method behind this, which the authors call mediation analysis, asks a careful question: if a risk group gets an outcome more often, how much of that extra runs in step with a third factor? It is a way of following a possible route through the numbers. It is not a way of proving that the route really exists, and certainly not proof that a change in that third factor would change the outcome.

Two ways to picture a signal on the route

Picture a busy shopping street on a wet afternoon. Wherever it is raining, you see open umbrellas. Count the umbrellas and you can tell fairly well how hard it is raining, yet nobody thinks the umbrellas make the rain. A protein that rises along with a risk can be a useful marker in exactly that way, even if the protein itself does nothing.

Now picture the traffic between two cities. If about half the cars cross the same bridge, the bridge carries about half the flow. That tells you something useful about the route. It does not tell you that closing the bridge would halve the traffic, because drivers can simply take another road. If FABP4 moves in step with about half of the statistical link to the rhythm condition, FABP4 is that bridge: not a proven lever, but a route worth checking.

Whether FABP4 turns out to be an umbrella or a bridge that really carries the load is exactly what the study could not settle, and the authors say so too.

Who was studied, and what the research did not show

The study involved 319,048 UK Biobank participants who had neither heart condition at the start; the protein work used the 28,206 among them with data on plasma proteins.⁠1 The abstract does not report how old they were, how long the follow-up lasted or which measurements together determined cardiometabolic health and frailty.

Three limitations matter most. First, this is an observational study: it shows that the combination goes together with more risk, not that the combination causes that risk.⁠1 Second, the protein analyses were exploratory, and the authors call FABP4 a preliminary signal that still needs to be checked in independent groups of participants.⁠1 Third, the abstract reports no FABP4 test for everyday care, and nothing in it shows that lowering FABP4, or taking any other step, changes what happens to the heart.

In short, and what you can do now

A GP listens with a stethoscope to the heart of a relaxed, smiling patient in their fifties in a bright consulting room

In short: a body with a metabolism under strain and a body losing reserve were, taken together, linked with a clearly higher chance of an irregular heart rhythm and of a heart that pumps too weakly, almost three times the risk for the pumping condition, and with a higher chance of going on to develop both.⁠1 Together, the two weighed more than their parts added up. A protein released by fat cells, FABP4, was the most consistent signal on that route, but the study is observational and the authors call FABP4 preliminary, still to be checked in other groups.⁠1 In the Netherlands, that pumping condition alone accounted for more than 32,200 hospital admissions in 2023.⁠3

First, look at the pieces together. Your metabolism and how much reserve your body has are worth judging side by side, not one at a time.

Second, take questions about your own heart rhythm, such as a heart that skips or races, to your GP. Thuisarts, the patient website of the Nederlands Huisartsen Genootschap, has a page on irregular heart rhythm with a link on who to call if it is urgent.⁠8

Third, start from where you stand. How your own heart and blood vessel health is doing today is the open question this piece cannot answer for you. The heart and blood vessel scan below gives you a first picture, as insight; the scan is not a diagnosis.

Frequently asked questions

What is FABP4?

A protein made mainly in fat cells and certain immune cells that plays a role in how the body responds to insulin.⁠6 Fat cells release it, and a review article from UMC Utrecht looked at what it means for the heart and blood vessels in an ageing population.⁠7

Does frailty cause an irregular heart rhythm?

This study does not show that. It is observational: being both cardiometabolically unhealthy and pre-frail or frail went with a higher risk, and that is not cause and effect, but a link.⁠1

Can FABP4 tell me my own risk?

Not yet. The authors call FABP4 a preliminary signal that still needs to be checked in independent groups of participants, and the summary reports no test for everyday care.⁠1

How is frailty assessed?

The summary of the new study does not report how frailty was measured. One short frailty score, the Clinical Frailty Scale, is assessed by looking at the person, without equipment or special training, according to a researcher at Juntendo University.⁠5

Where do I go with questions about my own heart rhythm?

To your GP. Thuisarts, the patient website of the Nederlands Huisartsen Genootschap, has a page on irregular heart rhythm with a link on who to call if it is urgent.⁠8

Will the heart and blood vessel scan show whether something is wrong with my heart rhythm?

No. The scan is not a diagnosis. The scan gives you insight into where you stand today; questions about your own rhythm belong with your GP.⁠8

Sources

Every source below was checked on the day this article was published. The numbering follows the text.

  1. Cui C, Liu B, Zhang G, Du Z, Cheng W. Cardiometabolic health-frailty phenotypes and bidirectional transitions between atrial fibrillation and heart failure: multistate trajectories and proteomic signatures. The Journal of Nutrition, Health and Aging, 2026. PMID 42858504. doi.org/10.1016/j.jnha.2026.101006
  2. VZinfo (RIVM). Hartfalen. Volksgezondheid en Zorg, accessed 2026. vzinfo.nl
  3. VZinfo (RIVM). Hartfalen. Volksgezondheid en Zorg, accessed 2026. vzinfo.nl
  4. Peng Q, Ma T, Gao M, et al. Association of single and multiple cardiometabolic diseases with atrial fibrillation: a prospective cohort study. Open Heart, 2025. doi.org/10.1136/openhrt-2024-003034
  5. Taisuke Nakade, Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine. Study reveals clinical frailty scale as a quick predictor of patient risk after heart failure administration. EurekAlert!, 2025. eurekalert.org
  6. Furuhashi M, Saitoh S, Shimamoto K, Miura T. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clinical Medicine Insights: Cardiology, 2014. doi.org/10.4137/cmc.s17067
  7. van der Ark-Vonk EM, Puijk MV, Pasterkamp G, van der Laan SW. The Effects of FABP4 on Cardiovascular Disease in the Aging Population. Current Atherosclerosis Reports, 2024. doi.org/10.1007/s11883-024-01196-5
  8. Thuisarts.nl (NHG). Boezem-fibrilleren (atrium-fibrilleren): advies van artsen. Accessed 2026. thuisarts.nl

Quotations from English have been translated by BioProfile.

See where your heart and blood vessels stand today

A short set of questions gives you a first picture of the health of your heart and blood vessels. It is insight into where you stand, not a diagnosis, and a starting point you can come back to.

Free, about 3 minutes. An analysis of your answers, never a diagnosis.